News

PrEP safety, side effects of integrase inhibitors, HIV and children and global access to dolutegravir – reports from four meetings + other news including reduced dose maintenance studies…

News from Durban on HIV prevention including TasP and PrEP, paediatrics, TB and cure research – plus news about PrEP in the UK…

Reports from AIDS 2016 include PrEP and new drugs plus news from the pre-conference paediatric and TB workshops…

Simon Collins, HIV i-Base On 29 July 2016, the PROUD study website announced that the study will close without being able to continue to provide participants with oral PrEP. [1] The press release blames NHS England for cancelling the previous …

Simon Collins, VIH i-Base Los resultados del estudio PARTNER publicados en coincidencia con la conferencia AIDS 2016, que se inaugura en Durban (Sudáfrica) la próxima semana, revelan el impacto del tratamiento antirretroviral en la drástica reducción de la transmisión del …

NOTE: For later pipeline reports produced as the i-Base Fit For Purpose publications please see: https://i-base.info/hiv-pipeline-reports-2010-2019 From 2010 – 2016,  i-Base collaborated with Treatment Action Group (TAG) to produce an annual review of latest research. Since 2017, i-Base produce separate …

El siguiente cuestionario está relacionado con el estudio PARTNER que fue publicado en la edición del 12 de julio de 2016 de Journal of the American Medical Association (JAMA), cuya versión completa está disponible de forma gratuita. A continuación se …

Full paper published in JAMA as open access article.

Annual overview of HIV and TB pipeline research: paediatrics and adults

NHS decision to block PrEP, reports from BHIVA, EASL, CROI and HIV and Women conferences, use of HPV vaccine – and remembering i-Base founder Paul Blanchard…

Simon Collins, HIV i-Base The dominant market structure where pharmaceutical drug pricing blocks access to otherwise cheap-to-manufacture life-saving medicines from the people who most need them, was highlighted by international activists on Friday. This was a coordinated action linking community-based …

Sign on now… Approved in the US, France, Canada and South Africa. Public discussion banned by NHS England… access blocked in UK

Dozens of studies from CROI 2016: PrEP, new HIV drugs, paediatric and access… plus STOP-PRESS news that NHS England blocks PrEP in the UK…

First reports from CROI in Boston: dozens of studies and an overview of other issues…

Access to care in the UK, generic dolutegravir at $44 per year, new US and WHO guidelines, PrEP submited for EU approval…

This manual contains eight modules with questions and answers. This manual is designed for people with no previous knowledge of the subjects. Read the manual online – please check dates for each section. The current online web pages for sections 1 to …

i-Base will run a reduced treatment information service between Christmas and the New Year. If you have an urgent enquiry during this period, please contact your clinic. The phoneline will be closed between 23rd December and 4th January. We will …

On 16 December 2015, Channel 4 news include a short story about PrEP. Watch on YouTube. The report included interviews with activists from i-Base and the community PrEP organisations I Want PrEP Now and Prepster. We hope this raises the …

News and reports to challenge HIV treatment and prevention strategies for 2016… EACS 2015, access, guidelines, PrEP

For more than two decades, AEGiS was the largest and most comprehensive online HIV library.  It was also one of the first organisations to prioritise open-access to resources on HIV and AIDS.  Unfortunately, increasing difficulty with sustaining funding meant that this …